Home Automation News New to The Avenue TV Pronounces 4 Company Interviews on – On...

New to The Avenue TV Pronounces 4 Company Interviews on – On Time Techy

NEW YORK, June 20, 2022 (GLOBE NEWSWIRE) — FMW Media’s New to The Avenue TV, a nationally syndicated TV current, declares episode #356 airing tonight, Monday, June 20, 2022, at 10:30 PM PT on the Fox Enterprise Group.

New to The Avenue’s 356th TV episode airs tonight, that features the subsequent 4 (4) Companies and their representatives:

1). Tonix Prescribed drugs, Inc.’s (NASDAQ: TNXP) interview with Dr. Seth Lederman, MD, and CEO.

2). Sekur Private Data, Ltd.’s (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) interview with Mr. Alain Ghiai, CEO.

3). PetVivo Holdings, Inc.’s (NASDAQ: PETV) (NASDAQ: PETVW) interview with Mr. Mark Middleton, Nationwide Product sales Director.

4). Leflair’s (Society Cross, Inc. subsidiary) (NASDAQ: SOPA) interview with Mr. Loic Gautier, CEO.

Tonight, CEO, Dr. Seth Lederman, MD at Tonix Prescribed drugs, Inc. (NASDAQ: TNXP), is once more inside the studio on the Nasdaq Market speaking with New to The Avenue’s TV Host Jane King. Simply these days, TNXP launched info all through three oral exhibits on the 2022 American Transplant Congress held on the Center of Transplantation Sciences, Massachusetts Regular Hospital. TNX-1500 sees thrilling outcomes as a treatment in eliminating transplant rejections inside the coronary coronary heart and kidneys. By means of a collaboration with Massachusetts Regular Hospital, part of the Harvard Medical School, the TNX-1500 reveals info for potential product enchancment for therapeutic prevention of organ transplant rejection. TNX-1500 reveals thrilling outcomes to this point. A particular molecule, CD40-ligand (CD40L) appears to be the reason for transplant rejections. TNXP engineered a monotherapy to dam toxicities associated to CD40L; its TNX-1500 in animal analysis reveals actions to forestall rejections. Dr. Lederman talks regarding the monkeypox virus and compares the West African and Central African variants. The West African is the one the press tales about, with infections worldwide not exhibiting deadly. The Central African variant, with no reported circumstances, may be lethal. TNXP has two patented vaccines, one for smallpox and the other for monkeypox. TNX-801 is a horsepox-based dwell virus vaccine presently in enchancment to protect in direction of monkeypox and smallpox. The monkeypox vaccine is in-testing with lab monkeys; thus far, outcomes look promising in potential prevention. The Agency’s fibromyalgia and Prolonged-COVID analysis and medical trials proceed at TNXP. Thrilling events for the Agency for his or her novel therapies and coverings; Dr. Lederman will come once more on a future current with further updates. The on-screen QR code is obtainable in the midst of the current; receive or go to Tonix Prescribed drugs, Inc.https://www.tonixpharma.com/.

New to The Avenue TV, tonight is re-airing the in-studio interview on the Nasdaq Market with Mr. Alain Ghiai, CEO at Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0). Alain talks with TV Host Jane King regarding the Agency’s newest encrypted product, “Chat-by-Invite.” This new textual content material message machine, obtainable inside the USA, Canada, Australia, New Zealand, Switzerland, and most of Latin America and Europe, offers subscribers an utterly personal chat. It actually works when the Sekur subscriber sends a textual content material message to a recipient, and a hyperlink appears that opens into a private, protected platform hosted in Switzerland. Primarily, the chat occurs on the Swiss servers owned and managed by Sekur Private Data, Ltd. As quickly because the textual content material message session completes, the textual content material disappears. Hackers gained’t know regarding the transmission as a result of extraordinarily encrypted navy experience working the product. There isn’t any direct texting on open-source platforms, making them invulnerable to cybersecurity breaches. The SekurMail / SekurMessenger, SekurVoice, SekurProVideo Conference, and completely different merchandise will be discovered now or shortly. Sekur’s “Chat-by-Invite” app is obtainable on iOS and Android; go to Sekur.com to acquire it. Subscribers get cybersecurity protections not obtainable with open-source functions for inexpensive pricing. As an added security to subscribers, Sekur Private Data, Ltd operates its internet platforms and security corporations beneath the nation of Switzerland’s very highly effective privateness authorized pointers. The on-screen QR code is obtainable in the midst of the current; receive or go to Sekur Private Data, Ltd. – http://www.Sekur.com. This interview part initially aired on May 16, 2022.

Mr. Mark Middleton, Nationwide Product sales Director at PetVivo Holdings, Inc. (NASDAQ: PETV) (NASDAQ: PETVW) and TV Host Jane King will communicate on New to The Avenue TV tonight regarding the Agency and its merchandise. PetVivo Holdings, Inc. is a biomedical machine agency that manufactures, commercializes, and licenses progressive medical devices and therapeutics for companion animals. As PETV’s Nationwide Product sales Director, Mark talks about his historic previous contained in the pet merchandise enterprise, dealing with FDA manufacturing, product distributions, capital markets, and mergers/acquisitions. He sees himself as a great match at PETV; he understands the veterinarians (DVMs) needs for most interesting practices and product final result outcomes for his or her consumers’ animals. The injectable patented Spryng with OsteoCushion Experience treats osteoarthritis and joint afflictions whereas providing rehabilitation treatments for horses and canines and continues to develop as a reliable DVM treatment. Being a completely naturally derived product, Spryng is superior to rivals’ non-biological, synthetic merchandise, and the Spryng treatment lasts longer. The PETV has a experience group who understands science, finance, product sales/promoting and advertising and marketing, manufacturing, distribution, and so forth. With persistence, persistence, and follow-through, Mark sees a strong future for PETV. The on-screen QR code is obtainable in the midst of the current; receive or go to PetVivo Holdings, Inc. https://petvivo.com/ and Spryng with OsteoCushion Experience https://www.sprynghealth.com/.

On New to The Avenue TV tonight, Mr. Loic Gautier, CEO at Leflair, a Society Cross, Inc. (NASDAQ: SOPA) subsidiary, has his interview with TV Host Jane King. Loic offers viewers alongside together with his historic previous in e-commerce and on-line retail, how Leflair started and in the end turned a wholly-owned subsidiary of Society Cross, Inc. Digital commerce takes money and dedication to succeed, Loic explains the enterprise model at Leflair, an e-commerce platform specializing in model, and its improvement inside Vietnam and SE Asia. All through COVID-19 shutdowns, e-commerce web sites that provided non-essential objects/corporations had a difficult time, Leflair was able to outlive the downtrend all through 2020 and, in 2021, merged effectively into Society Cross, Inc., a Nasdaq public Agency. The connection between Leflair and Society is a win-win, giving Society Cross a enterprise vertical and Leflair entry to capital and human helpful useful resource abilities. Leflair matches utterly in Society Cross, Inc.’s objective to proceed developing the following expertise of digital ecosystems and loyalty functions in Southeast and South Asia markets. The on-screen QR code is obtainable in the midst of the current; receive or go to Leflair – https://leflair.com/en/ and Society Cross, Inc. – https://thesocietypass.com/.

About Tonix Prescribed drugs Holding Corp. (NASDAQ: TNXP):

Tonix Prescribed drugs Holding Corp. (NASDAQ: TNXP) is a clinical-stage biopharmaceutical agency centered on discovering, licensing, shopping for, and rising small molecules and biologics to take care of and forestall human sickness and alleviate struggling. Tonix’s portfolio consists of immunology, unusual sickness, infectious sickness, and central nervous system (CNS) product candidates. Tonix’s immunology portfolio consists of biologics to take care of organ transplant rejection, autoimmunity, and most cancers. TNX-15001 is a humanized monoclonal antibody specializing in CD40-ligand in enchancment to forestall allograft and xenograft rejection and for the treatment of autoimmune illnesses. A Half 1 study of TNX-1500 is predicted to be initiated inside the second half of 2022. Tonix’s unusual sickness portfolio consists of TNX-29002 for the treatment of Prader-Willi syndrome. The FDA has granted TNX-2900 Orphan-Drug Designation. Tonix’s infectious sickness pipeline consists of a vaccine in enchancment to forestall smallpox and monkeypox known as TNX-8013, next-generation vaccines to forestall COVID-19, and an antiviral to take care of COVID-19. Tonix’s lead vaccine candidates for COVID-19 are TNX-1840 and TNX-18504, dwell virus vaccines based on Tonix’s recombinant pox vaccine (RPV) platform. TNX-35005 (sangivamycin, i.v. decision) is a small molecule antiviral drug to take care of acute COVID-19 and is inside the pre-IND stage of enchancment. TNX-102 SL, (cyclobenzaprine HCl sublingual tablets) is a small molecule drug being developed to take care of Prolonged COVID, a persistent post-acute COVID-19 scenario. Tonix expects to impress a Half 2 study in Prolonged COVID inside the second quarter of 2022. The Agency’s CNS portfolio consists of small molecules and biologics to take care of ache, neurologic, psychiatric and behavior conditions. Tonix’s lead CNS candidate, TNX-102 SL, is in mid-Half 3 enchancment to deal with fibromyalgia, with a model new Half 3 study launched inside the second quarter of 2022. Lastly, TNX-13006 is a biologic designed to take care of cocaine intoxication that’s anticipated to start a Half 2 trial inside the second quarter of 2022 – https://www.tonixpharma.com. (1TNX-1500 is an investigational new biologic on the pre-IND stage of enchancment and has not been authorised for any indication.2TNX-2900 is an investigational new drug on the pre-IND stage of enchancment and has not been authorised for any indication.3TNX-801 is a dwell horsepox virus vaccine for percutaneous administration in enchancment to protect in direction of smallpox and monkeypox. TNX-801 is an investigational new biologic and has not been authorised for any indication.4TNX-1840 and TNX-1850 are dwell horsepox virus vaccines for percutaneous administration, in enchancment to protect in direction of COVID-19. TNX-1840 and TNX-1850 are designed to specific the SARS-CoV-2 spike protein from the omicron and BA.2 variants, respectively. TNX-1840 and TNX-1850 are investigational new biologics on the pre-IND stage of enchancment and haven’t been authorised for any indication. 5TNX-3500 is an investigational new drug on the pre-IND stage of enchancment and has not been authorised for any indication.6TNX-1300 is an investigational new biologic and has not been authorised for any indication.)

About Sekur Private Data Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0):

Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) is a Cybersecurity and Internet privateness provider of Swiss-hosted choices for protected communications and protected info administration. The Agency distributes encrypted emails, protected messengers, protected communication devices, protected cloud-based storage, disaster restoration, and doc administration merchandise. The Agency sells and serves consumers, corporations, and governments worldwide by authorised wholesalers, distributors, and telecommunications companies. Contact Sekur Private Data, Ltd. at [email protected] or go to  https://www.sekurprivatedata.com and  https://www.sekur.com.

About PetVivo Holdings, Inc. (NASDAQ: PETV) (NASDAQ: PETVW): 

PetVivo Holdings, Inc. (NASDAQ: PETV) (NASDAQ: PETVW) is an rising biomedical machine agency presently centered on manufacturing, commercializing, and licensing progressive medical devices and therapeutics for companion animals. The Agency’s approach is to leverage human therapies to take care of companion animals time-efficiently and less expensive. A key ingredient of this method is the accelerated timeline to revenues for veterinary medical devices that enter the market quite a bit earlier than further stringently regulated prescription drugs and biologics. PetVivo has a pipeline of seventeen merchandise to take care of animals and people. A portfolio of 19 patents protects the Agency’s biomaterials, merchandise, manufacturing processes, and use methods. The Agency’s lead product Spryng with OsteoCushion Experience, a veterinarian-administered, intraarticular injection to take care of lameness and completely different joint-related affliction, along with osteoarthritis, in canines and horses, is presently obtainable for enterprise sale to veterinarians – https://petvivo.com/ & https://www.sprynghealth.com/.

About Leflair, a Society Cross, Inc. (NASDAQ: SOPA) Subsidiary:

Leflair, based in Ho Chi Minh Metropolis, Vietnam, is an web premium outlet for Type, Magnificence, and Dwelling Furnishing merchandise. In December 2015, Leflair provided over 2,500 producers by way of its flash-sales model. Society Cross, Inc. (NASDAQ: SOPA) acquired Leflair’s belongings in February 2021 and relaunched Leflair once more onto the Vietnam market in September 2021. SOPA operates Leflair.com, Vietnam’s foremost lifestyle e-commerce platform. Society Cross, Inc. is developing the next-generation loyalty and data-focused promoting and advertising and marketing platform in Southeast Asia and South Asia. The Agency’s experience ecosystem permits companies to work synergistically, transforming how consumers and retailers work collectively. It’s all about producing purchaser loyalty and earnings for retailers and ease of customer transactions. Additional transaction info turns into obtainable as further retailers and consumers register on the platform. Additional info expertise creates options to develop loyalty functions – https://thesocietypass.com/ & https://leflair.com/en/.

About FMW Media: 

FMW Media operates certainly one of many longest-running US and Worldwide sponsored and Syndicated Nielsen Rated programming TV producers, “New to The Avenue” and its blockchain current “Exploring The Block.” Since 2009, these producers have run biographical interview part reveals all through foremost U.S. Television networks. The paid for TV programming platforms can most likely attain over 540 million homes inside the US and worldwide markets. FMW’s New to The Avenue / Newsmax TV broadcasting platform airs its syndication on Sundays at 10 -11 AM ET. FMW will be certainly one of many nation’s largest patrons of linear television, prolonged and short-form paid programming – https://www.newsmaxtv.com/Reveals/New-to-the-Avenue & https://www.newtothestreet.com/.

Forward-Wanting Statements Disclaimer:

This press launch incorporates forward-looking statements inside Half 27A of the Securities Act of 1933, as amended, and Half 21E of the Securities Commerce Act of 1934. In some circumstances, it’s possible you’ll decide forward-looking statements by the subsequent phrases: “anticipate,” “think about,” “proceed,” “would possibly,” “estimate,” “anticipate,” “intend,” “might,” “ongoing,” “plan,” “potential,” “predict,” “problem,” “must,” “will,” “would,” or the damaging of these phrases or completely different comparable terminology. Nonetheless, not all forward-looking statements embrace these phrases. Forward-looking statements shouldn’t a guarantee of future effectivity or outcomes and received’t basically be appropriate indications of the events at which such effectivity or outcomes are achieved. This press launch should be considered in all filings of the Companies contained inside the Edgar Archives of the Securities and Commerce Price at www.sec.gov.

 CONTACT:

FMW Media Contact:

 Bryan Johnson
 +1 (631) 766-7462
 [email protected]

“New to The Avenue” Enterprise Enchancment Office
1-516-696-5900
[email protected]

{A photograph} accompanying this announcement is obtainable at https://www.globenewswire.com/NewsRoom/AttachmentNg/c058bf8b-54d1-439a-b8ea-4cdd07074ee2

LEAVE A REPLY

Please enter your comment!
Please enter your name here